And it’s still on the Market?

chantix-now-linked-to-heart-risk-july-05-2011

And it’s still on the Market?

Love the commercials with the “Non-Actors”
The U.S. Food and Drug Administration (FDA) sure missed the ball on this one. Pfizer’s once touted stop smoking drug has recreated yet another black eye: A study published in the Canadian Medical Association Journal found that Pfizer’s anti-smoking drug Chantix poses significant cardiovascular risks, and is linked to a 72% greater risk of hospitalization due to a serious adverse cardiovascular event like a heart attack or arrhythmia.

Since being “released” rather quickly in 2006, Chantix has been linked to serious psychiatric events. Those events had included suicide and depression. As a result of this a black box warning was placed on the drug. Among users, some people have endured alterations in hostility, behavior, depressed moods and suicidal thoughts or actions while using this stop smoking drug.

 

Pfizer Product To Stop Smoking May Raise Other Health Issues

 

 

Source read more here

Mark Barrus

Mark Barrus is the Director of Healthy Life Centers. I have been in the Hypnosis industry for over 20 years, and have written many articles about the efficacy and effectiveness of Hypnotherapy to overcome unwanted habits and actions. Twenty years of Case Study research and examination have helped me to inform the industry on the results and be a leader in the field. I originally worked with Dr. Richard Neves, the former head of the American Board of Hypnotherapy. training other Hypnotherapists in Advanced Smoking Cessation protocols. In February 2005, we also started the hypnosis organization Healthy Life Centers, which helps smokers find other reputable and properly trained hypnotherapists and hypnotists.

2 comments on “And it’s still on the Market?
  1. Dan Lester Love those ads with "actors" on TV.

  2. Alice Stacionis Did you know that it's estimated to be linked to over 400 suicide attempts?